4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Can-Fite BioPharma Ltd. (CANF) operates in the Biotechnology industry and is headquartered in Ramat Gan, Israel with about 5 employees. Its market capitalization is roughly ₪23 million. In the fiscal year ended 2025-12-31, CANF reported $0M in revenue and ($10M) in net income.
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $1M | $1M | $1M | — |
| Operating Income (EBIT) | ($10M) | ($8M) | ($8M) | ($10M) | — |
| Net Income | ($10M) | ($8M) | ($8M) | ($10M) | — |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $10M | $9M | $10M | $9M | — |
| Total Liabilities | $4M | $4M | $4M | $5M | — |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CANF viewer.
This page in other languages: עברית
About TickerBase · Data methodology & sources · Privacy · Terms